Bacillus Calmette Guerin (Alliance For Clinical Trials In Oncology)

N/A

Report date: 2025/06/10 20:00:09

Base Information

Drug NameBacillus Calmette Guerin (Alliance For Clinical Trials In Oncology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlliance For Clinical Trials In Oncology
China Registration ClassN/A

Develop Information

Active CompaniesAlliance For Clinical Trials In Oncology
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A